Scienza e Tecnologia
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals
Regulated information
November 13, 2025 - 7:45 a.m. CET
The Agfa-Gevaert Group in Q3 2025: continued decline in medical film, strong growth cloud and SaaS in HealthCare IT, soft markets in Digital Print & Chemicals
Mortsel (Belgium), November 13, 2025 – 7:45 a.m. CET – Agfa-Gevaert today commented on its results in the third quarter of 2025.
"Our third quarter results reflect ongoing pressure in the medical film markets. We are therefore accelerating and extending our savings efforts. We remain confident in the strategic direction of our growth engines. HealthCare IT’s shift to the cloud significantly strengthens the company’s long-term positioning as a global leader in Enterprise IT, while as expected temporarily impacting revenue and profit. This strategic evolution is supported by strong customer satisfaction and the signing of several high-value contracts in 2025. In Digital Printing Solutions, we continue to build a robust portfolio of high-end and mid-range offerings. Although current market conditions are currently slow, especially in the USA, the company anticipates renewed demand as economic stability returns. The Green Hydrogen Solutions business delivered a solid third quarter. Growth in Western markets is currently moderate but the company is successfully expanding its footprint in Eastern regions. The inauguration of a new ZIRFON membrane production unit in September marks a significant milestone in our commitment to the clean energy transition." Pascal Juéry, President and CEO of the Agfa-Gevaert Group.
Acceleration and extension of restructuring plans
(*) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’ (EBIT)/EBITDA
Definitions of non-IFRS financial measures (APMs): see further .
The consolidated statements are included at the end of this press release. They are an integral part of this document.
Agfa-Gevaert Group
(*) before adjustments and restructuring expenses
(**) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’(EBIT)/EBITDA
Third quarter
Financial position and cash flow
Outlook
This outlook is based on the current economic environment.
2025 outlook per division:
Not taking into account the remaining outstanding receivable of 25 million euro from the sale of the Offset Solutions business to Aurelius, Agfa expects a slightly negative net cash flow for the full year 2025. The amount of 25 million euro consists of 6 million euro which is undisputed and 19 million euro which is disputed and pending on the conclusion of the independent expert’s review. The expert has recently issued a draft report on this matter. The final report currently has been announced for the end of the year.
HealthCare IT
(*) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’(EBIT)/EBITDA
Third quarter
Digital Print & Chemicals
(*) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’(EBIT)/EBITDA
Third quarter
Division performance
Digital Printing Solutions
Green Hydrogen Solutions
Radiology Solutions
(*) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’(EBIT)/EBITDA
Third quarter
Contractor Operations and Services – former Offset
(*) Adjusted EBIT/EBITDA with the deduction of adjustments and restructuring expenses reconciles to ‘Results from operating activities’(EBIT)/EBITDA
Conference call for analysts and investors
Pascal Juéry, CEO of the Agfa-Gevaert Group, and Fiona Lam, CFO, will present the Q3 2025 results to analysts and investors at 11:00 a.m. CET on Thursday, November 13. This presentation can be accessed live upon registration via the agfa.com website and will be available on the website after the event.
End of message
Definitions of non-IFRS financial measures (APMs)
Contact:
Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
T +32 (0) 3 444 71 24
E viviane.dictus@agfa.com
The full press release and financial information is also available on the company's website: www.agfa.com.
Consolidated Statement of Profit or Loss (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Consolidated Statement of Comprehensive Income for the quarter ending September 2024 / September 2025 (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Consolidated Statement of Comprehensive Income for the period ending September 2024 / September 2025 (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Consolidated Statement of Financial Position (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Consolidated Statement of Net Debt (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Consolidated Statement of Cash Flows (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
The Group has elected to present a statement of cash flows that includes all cash flows, including both continuing and discontinued operations.
Consolidated Statement of changes in Equity (in million euro)
Unaudited, consolidated figures following IFRS accounting policies.
Reconciliation of non-IFRS information (in million euro)
(Adjusted) Free Cash Flow
Reconciliation of non-IFRS information (in million euro)
Adjusted EBIT
Working capital
Reconciliation of non-IFRS information (in million euro)
Net Financial Debt including IFRS 16
Net Financial Debt excluding IFRS 16
Evolution net financial debt excluding lease liabilities – linked with cashflow (in million euro)
Attachment
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti